Risk and response adapted therapy following autologous stem cell transplant in patients with newly diagnosed multiple myeloma (RADAR (UK-MRA Myeloma XV Trial): study protocol for a phase II/III randomised controlled trial
Kara‐Louise Royle, Amy Beth Coulson, Karthik Ramasamy, David A. Cairns et autres
gb, in, hr, jp, de, fr, ch (code pays fourni par la source)